Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Use this RGEN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RGEN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RGEN SEC filings page. Lician reads the product cache first so this HTML stays unique to Repligen Corporation even when a live quote feed is slow.
Latest cached year on this hub. Full RGEN income, balance, and cash tables.